Literature DB >> 24806969

Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review.

P D Marcato1, W J Fávaro, N Durán.   

Abstract

For many years, cisplatin has been used to treat many types of cancer, including urogenital, skin and lung cancers. Unfortunately, treatment with this drug causes serious side effects, such as severe toxicity; including nephrotoxicity, neurotoxicity, gastrointestinal toxicity, peripheral neuropathy, ototoxicity, asthenia and hematological toxicity.Therefore, the clinical use of cisplatin has been hampered.The incidence of nephrotoxicity frequently prevents the use of high enough doses to maximize the antineoplastic effects, and strict attention must be given to the hydration of cisplatin-treated patients to minimize kidney damage.Nanobiotechnology, or nanomedicine, was developed to mitigate, or even eliminate,the toxic effects of pharmaceutical compounds; for example, drug-targeting systems were developed to enable site specificity and to control the delivery drug. Therefore, biomedical nanotechnology researchers attempted to develop nanostructures not only to deliver chemotherapeutics to the desired treatment site but also to control when and how quickly the compounds are released. To achieve these ends, a drug can either be encapsulated in a matrix or attached to a particle surface. Studies concerning the encapsulation of cisplatin in liposomes, polymeric nanoparticles, solid lipid nanoparticles and carbon nanotubes, as well as the immobilization of cisplatin on metallic nanoparticles, have already been published. The association of cancer treatment, particularly chemotherapeutics, with nanotechnology is currently one of the most exciting areas of research. In this mini-review, cisplatin will be discussed in terms of its efficacy against many cancers, including bladder cancer. Additionally, established nanostructure-based drug delivery systems for cisplatin and their efficacy against different types of cancer will be reviewed. Because cisplatin is a standard treatment with good performance statistics and with an effective renal function-glomerular filtration rate, we expect that this review will be helpful for future research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806969     DOI: 10.2174/1568009614666140508154020

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  7 in total

1.  Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.

Authors:  H Liang; H-Z Liu; H-B Wang; J-Y Zhong; C-X Yang; B Zhang
Journal:  Inflamm Res       Date:  2017-02-21       Impact factor: 4.575

2.  Selenium Status in Diet Affects Nephrotoxicity Induced by Cisplatin in Mice.

Authors:  Shuang Liu; Xing Wen; Qihan Huang; Minghui Zhu; Jun Lu
Journal:  Antioxidants (Basel)       Date:  2022-06-10

3.  Lung cancer cellular apoptosis induced by recombinant human endostatin gold nanoshell-mediated near-infrared thermal therapy.

Authors:  Haiqing Luo; Meng Xu; Xinhai Zhu; Jianfu Zhao; Shiqing Man; Haoran Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Chemosensitizing Effect of Astragalus Polysaccharides on Nasopharyngeal Carcinoma Cells by Inducing Apoptosis and Modulating Expression of Bax/Bcl-2 Ratio and Caspases.

Authors:  Zhen Zhou; Minhua Meng; Haifeng Ni
Journal:  Med Sci Monit       Date:  2017-01-26

5.  PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.

Authors:  Orielyz Flores; Santimukul Santra; Charalambos Kaittanis; Rania Bassiouni; Amr S Khaled; Annette R Khaled; Jan Grimm; J Manuel Perez
Journal:  Theranostics       Date:  2017-06-24       Impact factor: 11.556

6.  Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.

Authors:  Rongrong Zhang; Yun Ru; Yiping Gao; Jinyin Li; Shilong Mao
Journal:  Drug Des Devel Ther       Date:  2017-09-05       Impact factor: 4.162

7.  Effect of Suramin on Renal Proximal Tubular Cells Damage Induced by Cisplatin in Rats (Histological and Immunohistochemical Study).

Authors:  Eman Ali El-Kordy
Journal:  J Microsc Ultrastruct       Date:  2019-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.